Dividend Overview
Dividend Yield
1.73%
Dividend / Share
$3.21
Astrazeneca plc
Exchange: NASDAQSector: HealthcareIndustry: Drug Manufacturers - General
AstraZeneca (LSE/STO/Nasdaq: AZN ) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca.
Did you know?
Pays a 1.73% dividend yield.
Current Price
$184.74
-1.40%GoodMoat Value
$228.37
23.6% undervaluedProfile
Valuation (TTM)
Market Cap$286.51B
P/E27.58
EV—
P/B5.89
Shares Out1.55B
P/Sales4.74
Revenue$60.44B
EV/EBITDA15.28
Astrazeneca plc (AZN) Dividends
Key Metrics
Market Cap
$286.51B
P/E Ratio
27.58
Forward P/E
—
EPS
$6.54
PEG Ratio
4.71
Book Value
$31.38
Dividend Yield
1.73%
Profit Margin
17.19%
ROE
21.35%
Dividend History
Dividend Safety
AZN Dividend Analysis
Astrazeneca plc (AZN) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 1.73%. The annual dividend per share is $3.21.
P/E ratio: 27.58. Profit margin: 17.19%. Free cash flow: $11.78B. This page shows Astrazeneca plc's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Astrazeneca plc's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.